This topic contains a solution. Click here to go to the answer

Author Question: The __________ end of the humerus is at the shoulder. a. inferior (caudal) b. distal c. ... (Read 50 times)

K@

  • Hero Member
  • *****
  • Posts: 608
The __________ end of the humerus is at the shoulder.
 
  a. inferior (caudal)
  b. distal
  c. proximal

Question 2

encephal/o:
 
  a. electricity
  b. brain
  c. cell



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

peilian

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

C

Answer to Question 2

B




K@

  • Member
  • Posts: 608
Reply 2 on: Jun 27, 2018
Thanks for the timely response, appreciate it


komodo7

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Excellent

 

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Adolescents often feel clumsy during puberty because during this time of development, their hands and feet grow faster than their arms and legs do. The body is therefore out of proportion. One out of five adolescents actually experiences growing pains during this period.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library